Bill Title: To direct the Comptroller General of the United States to conduct a study to assess the key regulatory barriers that impede the expansion or siting of new pharmaceutical manufacturing facilities in the United States, and for other purposes.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced) 2025-02-18 - Referred to the House Committee on Energy and Commerce. [HB1405 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
No bill text drafts for US Congress HB1405 currently on file.

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress HB1405

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress HB1405 currently on file.

Social Comments on US HB1405